Training activity information

Details

Analyse, interpret and report the results of cases referred for abnormal scan findings, to include:

  • QFPCR
  • Microarray analysis
  • Karyotyping

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

  • Fetal anomaly screening programme (FASP) pathways
  • Principles of the assay
  • Best practice guidance
  • Local and national guidance
  • Quality control, including IQC, and EQA
  • Nomenclature, including use of ISCN
  • Interpretation of results
  • Variant classification
  • Reflex testing options
  • Disease mechanism
  • Test specific ethical issues
  • Test sensitivity and limitations, including mosaicism, and maternal cell contamination
  • Impact of confined placental mosaicism and fetal mosaicism on diagnosis
  • Local SOPs
  • Local format for reporting
  • Health and safety
  • Reporting of incidental findings including those independent of the referral reason, adult-onset conditions, and the implications for family members

Relevant learning outcomes

# Outcome
# 2 Outcome

Apply appropriate testing strategies to patients referred following abnormal ultrasound scan findings.

# 4 Outcome

Interpret chromosomal rearrangements, including implications for recurrence risk and future testing.

# 5 Outcome

Interpret genomic variants, including copy number changes and investigate the clinical significance of variants using bioinformatic tools using best practice guidelines.

# 6 Outcome

Interpret and report prenatal genomic findings, including appropriate recommendations for patient management.